Q3 2012 venture financing round-up: Uncertainty in medtech environment holds back investment flow
This article was originally published in Clinica
Executive Summary
Investor concerns regarding regulatory uncertainty, capital intensity and investment time horizons in the life sciences area have led to a drop in venture financing deals in the third quarter of this year.